ECSP993023A - TESTOSTERONE DERIVATIVES - Google Patents
TESTOSTERONE DERIVATIVESInfo
- Publication number
- ECSP993023A ECSP993023A ECSP993023A ECSP993023A EC SP993023 A ECSP993023 A EC SP993023A EC SP993023 A ECSP993023 A EC SP993023A EC SP993023 A ECSP993023 A EC SP993023A
- Authority
- EC
- Ecuador
- Prior art keywords
- testosterone derivatives
- compound
- tetosterone
- bucyclate
- oxyl
- Prior art date
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 150000003515 testosterones Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
La invención se relaciona con el nuevo andrógeno (7,17)-17-[[trans-4-butilciclohexil)carbonil]oxil]-7-metilestr-4-en-3-ona 8 MENT)buciclato) y cicloalquil ésteres relacionados. Este compuesto se diferencia favorablemente de otros derivados de testosterona en que tiene una buena solubilidad en medios oleosos. Presenta particularmente una buena potencia disuelta relativa a la tetosterona. El compuesto es particularmente adecuado para ser administrado por medio de inyección.The invention relates to the novel androgen (7,17) -17 - [[trans-4-butylcyclohexyl) carbonyl] oxyl] -7-methyl-str-4-en-3-one 8 MENT) bucyclate) and related cycloalkyl esters. This compound differs favorably from other testosterone derivatives in that it has good solubility in oily media. It has particularly good dissolved potency relative to tetosterone. The compound is particularly suitable to be administered by injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993023 ECSP993023A (en) | 1999-06-17 | 1999-06-17 | TESTOSTERONE DERIVATIVES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993023 ECSP993023A (en) | 1999-06-17 | 1999-06-17 | TESTOSTERONE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993023A true ECSP993023A (en) | 1999-09-09 |
Family
ID=42044012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993023 ECSP993023A (en) | 1999-06-17 | 1999-06-17 | TESTOSTERONE DERIVATIVES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993023A (en) |
-
1999
- 1999-06-17 EC ECSP993023 patent/ECSP993023A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2059115T3 (en) | CYCLODEXTRIN BASED IMPROVED ERYTHROPOYETINE FORMULATION. | |
| PL387009A1 (en) | Compositions containing non-saturatet polyol esters produced by metathesis | |
| UA91831C2 (en) | Injection device | |
| ES2193730T3 (en) | LIGANDOS OF RECEPTORS OF THYROID HORMONE AND GLUCOCORTIOIDS FOR THE TREATMENT OF METABOLIC DISORDERS. | |
| ES2186517A1 (en) | Fulvestrant formulation | |
| GB2438591B (en) | Injection device | |
| CY1107142T1 (en) | STANDARDIZATION INCLUDING FULVESTRANT | |
| DE69901250D1 (en) | 7.ALPHA.-METHYL 19-NORTESTOSTERONE UNDECANOAT WITH ANDROGENIC ACTIVITY | |
| IL153457A0 (en) | Improved injectable dispersions of propofol | |
| EP1273299A4 (en) | Minoxidil-containing preparations | |
| RU2001126719A (en) | Digester-substituted metalloprotease inhibitors | |
| AU2001272293A1 (en) | Device for administering an injectable product | |
| PA8565201A1 (en) | OSMOTIC SUPPLY SYSTEM | |
| AR018888A1 (en) | A TESTOSTERONE DERIVATIVE, USE OF THE SAME, A PHARMACEUTICAL FORMULATION THAT INCLUDES THE DERIVATIVE AND A KIT FOR MALE ANTI-CONCEPTION | |
| GEP20094648B (en) | Anti-parasiticidal composition | |
| IT1318401B1 (en) | N-DESACETYLTHIOCOLCHYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN. | |
| ES2165727T3 (en) | COMPOSITIONS OF ADMINISTRATION VIA ORAL WITH LOW DOSAGE OF CYTOTOXIC PROTEINS. | |
| DE60030710D1 (en) | RELEASE-REGULATORY PREPARATIONS | |
| TW200624017A (en) | Disk drive fixing structure | |
| IT246312Y1 (en) | PANEL CONNECTION SYSTEM THROUGH A DISPIGLE BAR FOR THE FORMATION OF MODULAR FURNITURE | |
| IT1317671B1 (en) | MODULAR ELEMENT FOR MODULAR FURNITURE. | |
| GT200100013S (en) | COLUMN FOR PUBLIC TELEPHONE. | |
| ECSP003420A (en) | USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES | |
| ITUD950183A3 (en) | CONNECTION SYSTEM FOR FURNITURE PARTS | |
| HK1055560A (en) | Improved injectable dispersions of propofol |